Have you ever wondered whether taking an MS drug is worth the risk of possible side effects? Read what the experts recommend when it comes to making this decision.
About 15 percent of people with MS have primary-progressive MS, a form of the disease that remains difficult to treat, despite FDA approval of the first drug to treat it.
Take just a couple of minutes to share your thoughts in our anonymous survey. Your input helps us tailor the Living with MS newsletter to bring you the most useful, supportive, and up-to-date content.
